RH
TEVA icon

Rayner & Haynor’s Teva Pharmaceuticals TEVA Stock Holding History

Rayner & Haynor’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$742K Sell
13,800
-425
-3% -$22.5K 0.57% 48
2014
Q2 		$746K Sell
14,225
-300
-2% -$15.3K 0.56% 49
2014
Q1 		$768K Sell
14,525
-150
-1% -$6.93K 0.6% 46
2013
Q4 		$588K Buy
+14,675
New +$578K 0.45% 60

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rayner & Haynor's TEVA Position: Q3 2014 in Review

Rayner & Haynor reduced its Teva Pharmaceuticals (TEVA) stake by 3% in Q3 2014, selling an estimated $22.5K and leaving 13,800 shares worth $742K. The position accounts for 0.57% of the portfolio, ranked #48.

Rayner & Haynor first reported a position in TEVA in Q4 2013 and has held it in 4 quarters since. The position peaked at $768K in Q1 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Rayner & Haynor held 13,800 shares of Teva Pharmaceuticals worth $742K as of Q3 2014.
  • Rayner & Haynor sold 425 Teva Pharmaceuticals shares in Q3 2014, an estimated $22.5K.
  • Teva Pharmaceuticals made up 0.57% of Rayner & Haynor's portfolio in Q3 2014, its #48 holding.
  • Rayner & Haynor first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • Rayner & Haynor's Teva Pharmaceuticals position peaked at $768K in Q1 2014.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Rayner & Haynor's 13F filing for Q3 2014, filed 14 Nov 2014.